Procter & Gamble Health · NSE: PGHL · BSE: 500126
Q1 FY20 results · Apr–Jun 2019
Procter & Gamble Health reported revenue from operations of ₹233.63 crore (up 6.1% from Q1 FY19) and net profit of ₹44.08 crore (down 8.7% from Q1 FY19) for Q1 FY20 (Apr–Jun 2019), on a standalone basis.
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 233.63 | 220.29 | +6.1% | 231.03 | +1.1% |
| Other income | 17.47 | 5.77 | +202.9% | 17.69 | −1.2% |
| Total income | 251.11 | 226.06 | +11.1% | 248.72 | +1.0% |
| Profit before tax | 67.50 | 51.71 | +30.5% | 63.49 | +6.3% |
| Net profit for the period | 44.08 | 48.31 | −8.7% | 40.71 | +8.3% |
| EPS, basic (₹) | 26.56 | 29.10 | −8.7% | 24.52 | +8.3% |
| Net margin (%) | 18.9 | 21.9 | 17.6 |
Standalone
- Filed with BSE
- 09 Aug 2019, 16:36 IST
- Board meeting
- 08 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE